Dr. Harry Ma, MD, PhD

Dr. Ma practices at The Vascular Experts - Rhode Island in Shelton, Connecticut.

Dr. Ma's NPI, 1174763957, was assigned on March 6, 2009. Dr. Ma graduated from Albert Einstein College of Medicine in 2004. Dr. Ma's Connecticut license number on file is 55618.

Dr. Ma's primary practice is The Vascular Experts - Rhode Island, at 6 Research Dr, Shelton, CT 06484 in Greater Bridgeport County. The practice phone is (401) 315-9575.

Dr. Ma's primary practice is The Vascular Experts - Rhode Island in Shelton, Connecticut. Dr. Ma is also affiliated with Lawrence + Memorial Hospital. The medical group on file is The Vascular Experts. Dmand AI also links Dr. Ma to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ma practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Ma's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Ma is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Ma's licenses on file in 5 states: Connecticut, Rhode Island, Oklahoma, Massachusetts and New York.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and lymphedema among the conditions Dr. Ma treats.

CMS data shows 3,257 Medicare services from Dr. Ma across 25 procedure codes in 2024, for 425 Medicare patients. Medicare paid $300,133 for them.

CMS counts 425 Medicare patients who saw Dr. Ma in 2024. The largest group is 75 to 84, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ma's median patient age at 73, with 51% women.

In 2024, Dr. Ma wrote 362 Medicare Part D claims for 122 patients. 51% of them were for generic drugs. CMS names the drug for 332 of them, across 7 drugs with 11 or more claims each, at $187,900 in total drug cost. In 2023, CMS named 264 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ma for performance year 2024, reported as part of a group. Dr. Ma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of leg revascularization (restoring blood flow) by Dr. Ma, more than 90% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Ma, published from 2012 to 2017. 2017 was the busiest year, with 2. The most frequent topics are Angioplasty, Balloon, Intermittent Claudication and Ischemia. Dr. Ma has published most often in Ann Vasc Surg. Dr. Ma's most frequent co-authors are John Blebea, MD, Mark David Iafrati, MD and Rafael Demarchi Malgor, MD.

CMS Open Payments shows 396 general payments to Dr. Ma from 42 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 69% of the total. AngioDynamics, Inc. paid the most, $35,757.

Dr. Ma graduated from Albert Einstein College of Medicine in 2004.

Dr. Ma is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.